Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03057782 · ClinicalTrials.gov registry record
Innovative Approaches to Assessment of Pain Control and Sedation in the NICU
A clinical trial, sponsored by Boston Children's Hospital.
- Completed
- Registry status
- 50
- Enrollment target
NCT03057782 is a clinical trial that has completed, run by Boston Children's Hospital. The registered enrollment target is 50 participants.
The verdict
NCT03057782 has completed, sponsored by Boston Children's Hospital.
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
Study Summary
It is difficult to assess pain and agitation in the NICU population because for a multitude of reasons including the pre-verbal nature of the patient population, the atypical pain response of premature infants, and the use of muscle relaxing medications that exclude motor response in pain assessments. Current assessment tools are based on physical exam and vital signs. The investigators propose to study the role of EEG and palmar conductance (PD) as additional tools in the assessment of pain and agitation
Interventions
- DEVICE Waveguard (TM) EEG cap
- DEVICE Micro Movement Sensor
- DEVICE Pico Movement Sensor
- DEVICE QS Piezostimulator
- DEVICE tactileTM sensory evaluator
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2016-10 |
| Est. Completion | 2022-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03057782
The ClinicalTrials.gov registry entry for NCT03057782 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Children's Hospital, which has 462 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Waveguard (TM) EEG cap is the first listed.
NCT03057782 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03057782 about?
NCT03057782 is a clinical study titled "Innovative Approaches to Assessment of Pain Control and Sedation in the NICU". It is difficult to assess pain and agitation in the NICU population because for a multitude of reasons including the pre-verbal nature of the patient population, the atypical pain response of premature infants, and the use of muscle relaxing medications that exclude motor response in pain assessment...
What is the current status of trial NCT03057782?
This trial is currently completed. The enrollment target is 50 participants. The study started on 2016-10. Estimated completion is 2022-09.
What interventions are being tested in trial NCT03057782?
The interventions under investigation include: Waveguard (TM) EEG cap (DEVICE), Micro Movement Sensor (DEVICE), Pico Movement Sensor (DEVICE), QS Piezostimulator (DEVICE), tactileTM sensory evaluator (DEVICE).
Who is sponsoring clinical trial NCT03057782?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.